Product Code: LAT FDA class 2 21 CFR 862.3870

Radioimmunoassay, Cannabinoid(S)

Clinical Toxicology

Radioimmunoassay for cannabinoids is a laboratory immunoassay method that uses radiolabeled tracers to detect and measure cannabinoid compounds in patient specimens, typically for drug screening or monitoring purposes in clinical toxicology. It is an FDA Class 2 device, requiring 510(k) premarket clearance. The product code is LAT, regulated under 21 CFR 862.3870, in the Clinical Toxicology specialty. Third-party review eligibility applies.

510(k)s
16
FEI Numbers
0
Registration Numbers
0
Unique Applicants
7
Years Active
24

Basic Information

Product Code
LAT
Device Class
FDA class 2
Regulation Number
862.3870
Medical Specialty
Clinical Toxicology
Review Panel
TX
Submission Type
1

Device Characteristics

GMP Exempt
Implant
Life Sustain/Support
Third Party
Summary Malfunction Reporting

510(k) Clearance History

Loading...

Related 510(k) Clearances

This FDA classification is associated with 16 510(k) clearances via K numbers.

K Number Device Name
K011426 PSYCHEMEDICS RIA CANNABINOID ASSAY
K961620 ABISCREEN ONLINE FOR CANNABINOIDS - ES 50/100
K936135 SUDORMED SWEAT PATCH SPECIMEN CONTAINER FOR COLLECTION OF MARIJUANA IN PERSPIRATION
K914507 DOUBLE ANTIBODY CANNABIONOIDS/QUAIL DETER IN URINE
K913414 ABUSCREEN(R) ONLINE(TM) FOR THC(50/100)(100TEST KT
K913865 URINE THC DIRECT RIA KIT (I-125)
K912574 ABUSCREEN ONLINE FOR THC (50 AND 100)
K904996 ABUSCREEN ONLINE TM FOR THC
K843534 ORAL THC-CANNABINOIDS DIRECT RIA KIT
K833911 URINE THC CANNABINOIDS DIRECT RIA KIT
K821965 ORAL THC-CANNABINOIDS DIRECT RIA KIT
K820903 THC-CANNABINOIDS DIRECT URINE RIA KIT
K820391 ABUSCREEN RADIOIMMUNOASSAY FOR CANNABI
K800246 EMIT -D.A.U. CANNABINOID URINE ASSAY
K791649 TETRAHYDROCANNALBINOL DIRECT BLOOD KIT
K781048 THC DIRECT RIA KIT